Megalabs

Megalabs is a prominent pharmaceutical company in Latin America, dedicated to providing affordable and reliable therapeutic solutions across various medical fields. With operations in 20 countries, primarily in the Americas, the company employs over 8,000 people, including a sales force of more than 3,000 representatives. A significant portion of Latin American doctors prescribe Megalabs products, with 42,000 prescriptions issued daily. The company is known for its commitment to innovation and high-quality production, adhering to standards set by the European Medicines Agency and ICH. Megalabs operates 18 production plants and 7 R&D centers, conducting over 80 projects annually. Its diverse portfolio includes more than 1,800 branded specialty prescription drugs, covering areas such as dermatology and osteoarticular treatments, as well as high-quality CBD products. Megalabs also collaborates with global firms to enhance its offerings and expand its reach in the market.